To provide the information your oncologist is not telling you or doesn't have the time to!
Explore a comprehensive range of insights and information within our ‘Varied Cancer Perspectives’ category. From melanoma to breast cancer, colorectal cancer to sarcoma, and beyond, this diverse collection delves into the multifaceted world of oncology. Gain a nuanced understanding of different cancer types, treatments, and the latest advancements in research. Whether you’re seeking knowledge on pediatric oncology, uveal melanoma, or desmoid tumors, our curated content provides a holistic view, offering valuable perspectives to empower and inform those navigating the complexities of cancer care. Join us on a journey through varied perspectives, ensuring a well-rounded understanding of the ever-evolving landscape of cancer.
In a groundbreaking development for patients with progressing desmoid tumors, the Food and Drug Administration (FDA) has granted approval for nirogacestat, a novel treatment provided by SpringWorks Therapeutics, Inc. This approval marks a significant milestone as the first-ever sanctioned therapy for desmoid tumors, offering hope and a new avenue of treatment for affected individuals. Let’s …
The latest development in breast cancer treatment brings hope and progress. On November 16, 2023, the Food and Drug Administration (FDA) approved capivasertib, in combination with fulvestrant, for adult patients battling hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative locally advanced or metastatic breast cancer. This approval marks a significant step forward for …
This is a new modified TIL protocol developed by Obsidian Therapeutics now open for enrollment at the Orlando Health Cancer Institute. All information provided here are from public sources and the protocol details can be found here. Please reach out to Karin Donaldson if interest in seeking this trial. This current protocol is specific for …
Pancreatic cancer is a highly aggressive form of cancer that often goes undetected until it reaches an advanced stage. To improve treatment outcomes, individuals must be aware of the early warning signs and seek medical attention promptly. This article aims to educate readers about the signs and symptoms of pancreatic cancer, emphasizing the importance of …
Living with neuroendocrine cancer can present a range of physical, emotional, and social challenges. However, with the right mindset and support, individuals can effectively manage symptoms and enhance their quality of life. Today we provide practical tips for handling common symptoms such as flushing, diarrhea, fatigue, and anxiety. Additionally, it highlights the role of supportive …
by Sajeve Thomas, MD, Oncologist Biliary tract cancer (BTC), a rare and aggressive form of cancer affecting the bile ducts, gallbladder, and liver, has historically been challenging to treat. However, there is hope on the horizon with the recent FDA approval of pembrolizumab (Keytruda, Merck) in combination with chemotherapy. This groundbreaking development offers new possibilities …
On November 7, 2023, the Food and Drug Administration (FDA) made significant updates to the existing indication of pembrolizumab (Keytruda, Merck) for the first-line treatment of patients with locally advanced unresectable or metastatic HER2-positive gastric or gastroesophageal junction (GEJ) adenocarcinoma. These changes come as part of the FDA’s commitment to advancing cancer treatment options, bringing …
Neuroendocrine tumors (NETs) are a rare type of cancer that originates in the neuroendocrine cells, which are found throughout the body. While these tumors can occur in various organs such as the pancreas, lungs, intestines, and appendix, they can also develop in other less common sites. In this article, we will dive into the basics …
I am very excited to announce the opening of a new Cellular Therapy by Tscan Therapeutics using TCR protocol at the Orlando Health Cancer Institute (OHCI) targeting Melanoma, Head/Neck Cancer, NSCLC, Ovarian, and HPV positive Anal-Cervical SCC. Information for this new open clinical trial was provided from a public source. Please reach out to Karin …
Embarking on the tumultuous journey that is stage IV melanoma, both patients and healthcare providers often find themselves in an intricate dance of vulnerability, resilience, and human connection. This is the poignant tale of a young man’s persistent battle against melanoma, his remarkable perseverance through a myriad of treatments, and the eventual moment of triumph …